Improving AAV and LV upstream manufacturing using cGMP lipid polymer nanocomplexes (LPNCs) from is a formulation a mixture Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 20 min 23 sec ✓ Published: 06-Jun-2023
Description: With success of cell and gene therapies and exponentially increasing demand, the second wave of viral vector manufacturing is focused on large-scale suspension cell culture and/or adherent cell culture within intensified fixed bed bioreactors. In response to this need, Mirus Bio developed a novel HEK 293 cGMP cell transfection technology that increases AAV and LV titers 2-10-fold over existing technologies. The transfection reagent formulation is a mixture of lipid and polymer which enables the
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)